[Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?]

Subjects

Subjects :

Male
HBsAg
medicine.medical_specialty
End point
Ideal (set theory)
Carcinoma, Hepatocellular
Hepatitis B Surface Antigens
business.industry
Liver Neoplasms
Antiviral therapy
General Medicine
Hepatitis B
medicine.disease
Virology
Gastroenterology
Antiviral Agents
Hepatitis B, Chronic
Chronic hepatitis
Internal medicine
medicine
Carcinoma
Humans
Female
business

Details

ISSN :

22336869

Volume :

63

Issue :

5

Database :

OpenAIRE

Journal :

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Accession number :

edsair.doi.dedup.....b937ebc5b95f015a5b7e5cd498517c85